Novartis partners with NHS to widen access to cholesterol drug Leqvio
Novartis has teamed up with Britain’s National Health Service (NHS) to widen the access to its cholesterol-lowering medicine Leqvio (inclisiran) for eligible patients across England. Under the collaboration,